Physician
Josef, Jeffrey
Josef, Jeffrey was paid $3.35M by Medicaid between Jan 2018 and Nov 2024, across 19 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 78% of everything it billed.
33Billing provider infoJOSEF, JEFFREY
SUFFERN, NY 10901
SUFFERN, NY 10901
33aNPI1326249558assigned 05/28/2007
33bProvider typeOphthalmology Physician
28Total paid$3.35M
24GClaims20,018
24DCodes billed19
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Ophthalmology Physician providers in New York
Rank by total paid#32 of 1,085
Median peer was paid$34K
This provider vs. median99×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,126 | $425K | |
| 2019 | 3,930 | $526K | |
| 2020 | 3,346 | $575K | |
| 2021 | 3,869 | $689K | |
| 2022 | 2,982 | $576K | |
| 2023 | 2,255 | $535K | |
| 2024incomplete | 510 | $23K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 78% | 4,419 | 2,573 | $2.60M |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 11% | 432 | 224 | $364K |
| 65800 | 5.2% | 4,013 | 2,620 | $175K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 1.9% | 1,884 | 1,671 | $65K |
| 92134 | 1.8% | 4,169 | 3,591 | $61K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 1.5% | 1,241 | 1,197 | $50K |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 601 | 465 | $17K |
| 92201 | <1% | 481 | 469 | $6K | |
| 92242 | <1% | 52 | 52 | $4K | |
| 92226 | <1% | 236 | 118 | $3K | |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 46 | 45 | $1K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 12 | 12 | $899.75 |
7 more codes
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 17 | $231.45 |
| 92202 | <1% | 41 | $116.10 | |
| 92020 | <1% | 14 | $10.48 | |
| 1036F | 0% | 779 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 781 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 788 | $0.00 |
| G9974 | Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.